Current problems in the diagnosis and treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia

Journal of Anesthesia

Volumn 22, Issue 2, 2008, Pages 125-130

  Sakaguchi, Masahiro ^a   Shime, Nobuaki ^b   Fujita, Naohisa ^b   Fujiki, Sakiko ^b   Hashimoto, Satoru ^b  

^a Otsu Municipal Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Clinical pulmonary infection score; Colonization; Hospital acquired pneumonia; Methicillin resistant Staphylococcus aureus; Therapeutic drug monitoring

Indexed keywords

ANTIINFECTIVE AGENT; HABEKACIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PULMONARY INFECTION SCORE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE;

FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PNEUMONIA, VENTILATOR-ASSOCIATED; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 44449113695     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-007-0600-4     Document Type: Article

References (19)

1. Lode H, Raffenberg M, Erbes R, Geerdes-Fenge H, Mauch H. Nosocomial pneumonia: Epidemiology, pathogenesis, diagnosis, treatment and prevention. Curr Opin Infect Dis. 2000;13:377-384.
2. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2003;53(RR-3):1-36.
3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887-892.
4. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med. 2001;29:N64-68.
5. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J. Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax. 1999;54:867-873.
6. Ho PL; For the Hong Kong Intensive Care Unit Antimicrobial Resistance Study (HK-ICARE) Group. Carriage of methicillinresistant Staphylococcus aureus, ceftazidime-resistant Gramnegative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med. 2003;31:1175-1182.
7. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121-1129.
8. Iwamoto T, Kagawa Y, Kojima M. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull. 2003;26:876-879.
9. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691-698.
10. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505-511.
11. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545-1549.
12. El-Solh AA, Aquilina AT, Dhillon RS, Ramadan F, Nowak P. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med. 2002;166:1038-1043.
13. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-706.
14. Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect. 1990;5:173-184.
15. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371-1375.
16. Cruciani M, Gatti G, Lazzarini L, Furlan G, Broccali G, Malena M, Franchini C, Concia E. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother. 1996;38:865-869.
17. Begg EJ, Barclay ML, Kirkpatrick CJ. The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol. 1999;47:23-30.
18. Torres A, el-Ebiary M. Invasive diagnostic techniques for pneumonia: protected specimen brush, bronchoalveolar lavage, and lung biopsy methods. Infect Dis Clin North Am. 1998;12:701-722.
19. Nseir S, Di Pompeo C, Pronnier P, Beague S, Onimus T. Nosocomial tracheobronchitis in mechanically ventilated patients: Incidence, aetiology and outcome. Eur Respir J. 2002;20:1483-1489.